Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma

Authors
Ozaki K. 1 , Hamaya T. 1 , Okita K. 1 , Hashimoto Y. 1 , Ohyama C. 1, 2 , Hatakeyama S. 2
Publisher
John Wiley & Sons
Language
English
State
Published
Year
2021
Organizations
  • 1 Department of Urology
  • 2 Department ofAdvanced Blood Purification Therapy|Hirosaki University Graduate School of Medicine
Share

Other records